Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,788.50
Bid: 1,788.50
Ask: 1,789.00
Change: 32.50 (1.85%)
Spread: 0.50 (0.028%)
Open: 1,743.50
High: 1,792.50
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: FTSE to open marginally higher

Tue, 12th Nov 2013 06:59

City sources predict the FTSE 100 will open around two points higher than yesterday's close of 6,728.37, tracking modest gains seen in the US last night and ahead of today's inflation figures.US markets ended slightly higher yesterday, with the Dow Jones Industrial Average hitting another record close, extending recent gains despite increased speculation surrounding the impending taper of quantitative easing.Today, all eyes will turn to German and UK inflation. Germany's consumer price index (CPI) is expected to remain unchanged at 1.2% in October. UK inflation is predicted to fall to 2.5% in October from 2.7% a month earlier. It will come a day ahead of the Bank of England's quarterly inflation report which will be watched closely to see if the central bank upgrades its economic forecasts. A change in economic projections could set the stage for bringing forward the expected date of its first interest rate hike.In other news, Energy Secretary Ed Davey is today expected to say that energy customers are not "cash cows" that can be "squeezed" to earn higher profits for shareholders. The Liberal Democrat Minister is set to urge businesses in the industry to become more transparent about exactly how they are tackling rising bills. CRH delivers modest Q3 rise in sales In this morning's company news, building materials giant CRH reported a small increase in like-for-like (LFL) sales in the third quarter, a strong turnaround after difficult weather conditions hit revenues in the first half. LFL sales in the three months to the end of September improved by 2% across the group, following a 6% decline in the first six months of the year. Overall sales revenue totalled €5.4bn during the period, some 2% ahead of the €5.3bn reported the year before.Babcock International Group has lifted its dividend by 10% to 6.9p due to a strong first half and a positive outlook. The engineering support services company achieved pre-tax profit of £105.9m in the six months through September, up 32% on the previous year's £80.4m.Real estate giant Land Securities posted improved revenue profit and net asset value (NAV) during the six months ended September 30th and said it is confident of delivering future progress. The UK's largest commercial property firm said basic NAV per share rose to 994p in the period from 959p a year earlier. Revenue profit rose to 8.9% to £156.5m.GlaxoSmithKline's heart disease drug, darapladib, has missed a key milestone in its development. The group said it would continued to investigate the darapladib inhibitor and would work to better understand the data, including evaluation of the patient sub-groups, and await the outcome of a second Phase III study of darapladib in acute coronary syndrome to help it determine its next stage of work. Monday's big moversYesterday, in a major blow to BSkyB and ITV, telecoms group BT confirmed that it has won the exclusive rights to broadcast live the UEFA Champions League and UEFA Europa League for three seasons. RSA Insurance was also a heavy faller after saying that "issues in the Irish claims and finance functions" were found during a routine internal audit, leading to the suspension of its Ireland Chief Executive Officer (CEO) and two of his senior executives. NR
More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.